Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. lorcaserin 75%
3. Anticoagulants 63%
4. Vitamin K 53%
5. Warfarin 47%
6. Stroke 47%
7. Vascular Diseases 45%
8. edoxaban 44%
9. Myocardial Infarction 43%
10. darapladib 41%
11. anacetrapib 40%
12. Overweight 39%
13. Blood Vessels 35%
14. Safety 34%
15. Confidence Intervals 33%
16. Abdominal Aortic Aneurysm 32%
17. Dabigatran 29%
18. Aortic Rupture 28%
19. Placebos 26%
20. Venous Thromboembolism 25%
21. Genetic Testing 22%
22. Acute Coronary Syndrome 22%
23. Pulmonary Embolism 21%
24. Consensus 21%
25. General Anesthesia 20%
26. Aneurysm 19%
27. Mortality 17%
28. Interleukin-6 17%
29. Outpatients 16%
30. Blood Pressure 15%
31. Heart Failure 15%
32. Randomized Controlled Trials 14%
33. Databases 13%
34. Therapeutics 13%
35. Incidence 12%
36. Kidney 11%
37. Professional Practice Gaps 10%
38. Fibromuscular Dysplasia 10%
39. Bicuspid Aortic Valve 10%
40. Thoracic Aortic Aneurysm 9%
41. Receptor, Serotonin, 5-HT2C 9%
42. Costs and Cost Analysis 9%
43. Aortic Diseases 9%
44. Patient Care 9%
45. Hemorrhage 8%
46. Insurance Coverage 8%
47. Serotonin Receptor Agonists 8%
48. Chronic Renal Insufficiency 8%
49. Family Planning Services 8%